Thursday 13 June |
Tesco |
WM Morrison Supermarkets |
Sirius Minerals |
Just Group |
Union Jack Oil |
Dignity |
JPJ Group |
Petropavlovsk |
Concepta |
Acacia Mining |
Friday 14 June |
MP Evans Group |
Serabi Gold |
Monday 17 June |
Challenger Acquistions |
FairFX Group |
Mobile Tornado |
CEPS |
Mission Marketing Group |
UK Commerical Property REIT |
Tuesday 18 June |
Plus500 |
Horizon Discovery Group |
Clearstar |
Coca-Cola HBC |
Evraz |
Ascent Resources |
Ergomed |
Rosenblatt Group |
Westminster Group |
Strategic Minerals |
Netscientific |
Wednesday 19 June |
Tarsus Group |
Cadongan Petroleum |
Whitbread |
Saga |
N4 Pharma |
Novacyt |
Woodbois |
Brive Bison |
Aura Energy |
ECSC |
Mereo Biopharma |
Midatech Pharma |
IN BRIEF: Midatech Pharma delisting and name change approved
Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Says resolutions put forward at general meeting, including name change, share consolidation and cancellation of AIM listing, approved. Under the consolidation, every 20 shares will be consolidated into one new ordinary share. Adds that ratio of American depositary shares will change to one ADS per five shares, from one ADS per 25 shares previously. Name change to Biodexa Pharmaceuticals PLC, effective on Monday, also approved. Listing of shares on AIM is expected to be cancelled a month from now. Its sole listing will be on Nasdaq.
Read more